References
- Bakke O. M., Scheline R. R. Analysis of simple phenols of interest in metabolism. I. Gas chromatographic separation and quantitative determination. Analytical Biochemistry 1969; 27: 451
- Borchert P., Wislocki P. G., Miller J. A., Miller E. C. The metabolism of naturally occurring hepatocarcinogen safrole to l‘-hydroxysafrole and the electrophilic reactivity of l’-acetoxysafrole. Cancer Research 1973; 33: 575
- Caujolle F., Meynier D. Hypothermic activity in the eugenol and safrole series. Annales Pharmaceutique Francaises 1960; 18: 601
- Delaforge M., Janiaud P., Chessebeuf M., Padieu P., Maume B. F. Possible occurrence of the epoxide-diol metabolic pathway for hepatocarcinogenic safrole in cultured rat liver cells, as compared with whole animal: a metabolic study by mass spectrometry,. Advances in Mass Spectrometry in Biochemistry and Medicine, A. Frigerio. Spectrum Publications, New York 1976; Vol. II: 65–89
- Delaforge M., Janiaud P., Maume B. F., Padieu P. Direct evidence of epoxide metabolic pathway for natural allyl-benzene compounds in adult rat liver cell culture,. Recent Development in Mass Spectrometry in Biochemistry and Medicine, A. Frigerio. Spectrum Publications, New York 1978; 521–539
- Delaforge M., Janiaud P., Levi P., Morizot J. P. Biotransformation of allylbenzene analogues in vivo and in vitro through the epoxide-diol pathway. Xenobiotica 1980; 10: 737
- Dorange J.-L., Delaforge M., Janiaud P., Padieu P. Pouvoir mutagène de métabolites de la voie époxyde-diol du safrol et d'analogues. Comptes Rendus des Sèances de la Société de Biologie et de ses Filiales 1977; 171: 1041
- Drinkwater M. R., Miller E. C., Miller J. A., Pitot H. C. The hepatocarcinogenicity of estragole (1-allyl-4-methoxybenzene) and 1′-hydroxyestragole in the mouse and the mutagenicity of l'-acetoxyestragole in bacteria. Journal of the National Cancer Institute 1976; 57: 1323
- Fieser L. F., Fieser M. Reagents for Organic Synthesis. John Wiley & Sons, New York 1967a; 135–137
- Fieser L. F., Fieser M. Reagents for Organic Synthesis. John Wiley & Sons, New York 1967b; 584
- Fischer I. U., Dengler H. J. Sensitive HPLC-assay for determination of eugenol in body fluids. Journal of Chromatography 1990, (in press)
- Fujii K., Jaffe H., Bishop Y., Arnold E., Mackintosh D., Epstein S. S. Structure-activity relations for methylenedioxyphenyl and related compounds on hepatic microsomal enzyme function. Toxicology and Applied Pharmacology 1970; 16: 482
- Gildemeister E., Hoffmann F. Die ätherischen Öle. Akademie-Verlag, Berlin 1960; Bd IIId: 442
- Guenther E. The Essential Oils. D. van Nostrand, Princeton, New Jersey 1950; Vols I-IV
- Hackett P. H., Mammoth C., Rodriguez G., Roach R. C. Clove cigarettes and high-altitude pulmonary edema. Journal of the American Medical Association 1985; 253: 3551
- Hartiala K. J. W., Pulkkinen M., Ball P. Inhibition of β-D-glucosiduronic acid conjugation by eugenol. Nature 1966; 210: 739
- Hirs A. Sales of clove cigarettes gain in U.S.; Healthy questions emerge. Tobacco International 1984; 28: 57
- Homburger F., Kelly T., Friedler G., Russfield A. B. Toxic and possible carcinogenic effects of 4-allyl-1,2-methylene-dioxybenzene (safrole) in rats on deficient diets. Medicina Experimentalis 1961; 4: 1
- IARC Monographs. Evaluation of the carcinogenic risk of chemicals to humans. IARC, LyonFrance 1985; Vol. 36: 75–97
- Jenner P. M., Hagan E. C., Taylor J. M., Cook E. L., Fitzhugh O. G. Food flavorings and compounds of related structure. Food and Cosmetics Toxicology 1964; 2: 327
- Klungsøyr J., Scheline R. R. Metabolism of safrole in the rat. Acta Pharmacologica et Toxicologica 1983; 52: 211
- Lavoie E. J., Adams J. D., Reinhardt J., Rivenson A., Hoffmann D. Toxicity studies on clove cigarette smoke and constituents of clove: determination of the LD50 of eugenol by intratracheal instillation in rats and hamsters. Archives of Toxicology 1986; 59: 78
- Long E. L., Nflson A. A., Fitzhugh Q. E., Hansen W. H. Liver tumors produced in rats by feeding safrole. Archives of Pathology 1963; 75: 595
- Mass Spectra of Compounds of Biological Interest, S. P. Markey, W. G. Urban, S. P. Levine. National Technical Information Service, US Department of Commerce, Springfield, Virginia 1977; Vol. 2: 347, Part 1
- Miller E. C., Swanson A. B., Phillips D. H., Fletcher T. L., Liem A., Miller J. A. Structure-activity studies of the carcinogenities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole. Cancer Research 1983; 43: 1124
- Morbidity and Mortality Weekly Report 1985; Vol. 34: 297
- Muskiet F. A. J., van der Meulen J., Bouwman J., Höhn M. Mass Spectra of L-dopa, Catecholamines and their Metabolites. Varian MAT GmbH, Bremen 1979; 44
- Pearl I. A. Studies on lignin and related products XIV. Journal of Organic Chemistry 1958; 24: 736
- Sandler M., Ruthven C. R. J. The biosynthesis and metabolism of the catecholamines,. Progress in Medicinal Chemistry, G. P. Ellis, G. B. West. Butterworth, London 1969; Vol. 6: 200–265
- Schlenk H., Gellerman J. L. Esterification of fatty acids with diazomethane on a small scale. Analytical Chemistry 1960; 32: 1412
- Schröder V., Vollmer H. Über die Ausscheidung von Thymol, Carvacrol, Eugenol und Guajacol und die Verteilung dieser Substanzen im Organismus. Naunyn-Schmiedebergs Archiv für Experimentelle Pathologie und Pharmakologie 1932; 168: 331
- Solheim E., Scheline R. R. Metabolism of alkenebenzene derivatives in the rat. I. p-Methoxyallylbenzene (estragole) and p-methoxypropenylbenzene (anethole). Xenobiotica 1973; 3: 493
- Solheim E., Scheline R. R. Metabolism of alkenebenzene derivatives in the rat. II. Eugenol and isoeugenol methyl ethers. Xenobiotica 1976; 6: 137
- Sorber H. A., Hollander F., Sober E. K. Toxicity of eugenol: determination of LD50 on rats. Proceedings of The Society for Experimental Biology and Medicine 1950; 73: 148
- Stenhagen E., Abrahamsson S., McLafferty F. W. Registry of Mass Spectral Data. John Wiley, New York 1974; Vol. 2: 1403
- Stillwell W. G., Carman M. J., Bell L., Horning M. J. The metabolism of safrole and 2′,3′-epoxysafrole in the rat and guinea pig. Drug Metabolism and Disposition 1974; 2: 489
- Sutton J. D., Songster S. A., Caldwell J. Dose-dependent variation in the disposition of eugenol in the rat. Biochemical Pharmacology 1985; 34: 465
- Taylor J. M., Jenner P. M., Jones W. I. A comparison of the toxicity of some allyl, propenyl, and propyl compounds in the rat. Toxicology and Applied Pharmacology 1964; 6: 378
- Ullmann E. Klopädie der technischen Chemie Bd 20. Verlag Chemie, Weinheim 1981; 242
- Food US, Drug Administration. Scientific Literature: Review of eugenol and related substances in flavor usage. 1978; 1–134
- Weinberg J. E., Rabinowitz J. L., Zanger M., Gennaro A. R. 14C-Eugenol: I. Synthesis, polymerization and use. Journal of Dental Research 1972; 51: 1055
- Williams R. T. Detoxication mechanisms—The metabolism and detoxication of drugs, toxic substances and other organic compounds, 2nd edn. Chapman & Hall, London 1959; 796